Bavarian Nordic appoints board observer intended to take chairmanship
According to plans, GSK veteran Luc Debruyne will begin as an observer to the board of the Danish drugmaker before being nominated as chairman in 2023.
.jpg)
by marketwire, translated by daniel pedersen
On Tuesday, Bavarian Nordic announced in a press release the appointment of Luc Debruyne as observer to the board of directors with the intention for him to succeed Gerard van Odijk as chairman next year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Bavarian Nordic wins decade-long contract with Canada
For subscribers
